Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
Colorectal cancer (CRC) is characterized by recurrent mutations deregulating key cell signaling cascades and providing the cancer cells with novel functional traits. Among the most frequent mutations in CRC are gain-of-function missense mutations in KRAS ...
Oncotarget . 2015 Jul 30;6(25):20785–20800. doi: 10.18632/oncotarget.4750 Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance Markus Morkel Markus Morkel 1 Charité Universitätsmedizin Berlin, Institute of Pathology, Laboratory of Molecular Tumor Pathology and Systems Biology, Berlin 10117, Germany Find articles by Markus Morkel 1 , Pamela Riemer Pamela Riemer 1 Charité Universitätsmedizin Berlin, Institute of Pathology, Laboratory of Molecular Tumor Pathology and Systems Biology, Berlin 10117, Germany 2 DKTK, German Consorti
saved by
related reading
- Mutational interactions define novel cancer subgroupsnature.com
- The current state of the art and future trends in RAS-targeted cancer therapiesnature.com
- Pancreatic Cancer - PMCncbi.nlm.nih.gov
- The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decadesstatnews.com
- Epigenetic regulation during cancer transitions across 11 tumour typesnature.com
- Has pancreatic cancer met its match?worksinprogress.co
- A simple algebraic cancer equation: calculating how cancers may arise with normal mutation ratesbmccancer.biomedcentral.com
- A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damagenature.com
- Loss and revival of androgen receptor signaling in advanced prostate cancernature.com
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PMCpmc.ncbi.nlm.nih.gov
- Why are early-onset colorectal cancer rates spiking?communitymorgue.com
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PubMedpubmed.ncbi.nlm.nih.gov